About Pharmapace
Pharmapace is a company based in San Diego (United States) founded in 2013 was acquired by WuXi AppTec in May 2019. Pharmapace offers products and services including Biostatistics Services, Data Management, Statistical Programming, and Regulatory Submissions. Pharmapace operates in a competitive market with competitors including SSI Strategy, Fusion Antibodies, Health Decisions, Antios Therapeutics and Everest Clinical Research, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmapace, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
WuXi AppTec
(May 05, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pharmapace
Pharmapace offers a comprehensive portfolio of products and services, including Biostatistics Services, Data Management, Statistical Programming, and Regulatory Submissions.
Offers statistical planning and analysis for clinical trials
Manages clinical data for drug development processes
Develops programs for data analysis in research studies
Handles submissions for drug approvals and compliance
Funding Insights of Pharmapace
Detailed funding history for Pharmapace
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Pharmapace
Pharmapace has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include WuXi AppTec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of CRO and CDMO services
|
Locked | Locked | Locked |
Investor details for Pharmapace
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharmapace
Investment portfolio details for Pharmapace
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pharmapace
Detailed financials for Pharmapace
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmapace Comparisons
Peer comparison for Pharmapace
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharmapace
Pharmapace operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SSI Strategy, Fusion Antibodies, Health Decisions, Antios Therapeutics and Everest Clinical Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacovigilance and medical affairs services are offered for drug development.
|
|
| Locked | Locked | Locked |
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
|
|
| Locked | Locked | Locked |
CRO focused on clinical trial services for data management, monitoring and biostatistics
|
|
| Locked | Locked | Locked |
Innovative therapies for treating and curing viral diseases are developed.
|
|
| Locked | Locked | Locked |
Full-service clinical research services are provided to life science industries.
|
|
| Locked | Locked | Locked |
Regulatory and pharmacovigilance support is provided for product lifecycles.
|
Detailed competitors of Pharmapace
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmapace
Complete news archive for Pharmapace
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmapace
Pharmapace was founded in 2013.
Pharmapace is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Founded in 2013 and based in San Diego, United States, Pharmapace operates in the silicon photonics sector. Components such as lasers, modulators, and photodiodes are designed and manufactured for ethernet modules, co-packaged optics, lidar systems, and biosensors. Wafer-scale integration is utilized to produce compact, hermetically sealed products with enhanced thermal performance. The platform is adapted for O- and C-band uses, supported by a high-volume silicon foundry for scalable production.
Pharmapace's top competitors include SSI Strategy, Fusion Antibodies and ProductLife Group.
Pharmapace offers Biostatistics Services, Data Management, Statistical Programming, and Regulatory Submissions.
Pharmapace has 1 investor. Key investors include WuXi AppTec.